<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02690584</url>
  </required_header>
  <id_info>
    <org_study_id>2015/1456</org_study_id>
    <nct_id>NCT02690584</nct_id>
  </id_info>
  <brief_title>Metacognitive Therapy for Post-concussive Symptoms After Mild Traumatic Brain Injury</brief_title>
  <official_title>Metacognitive Therapy for Post-concussive Symptoms After Mild Traumatic Brain Injury</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Norwegian University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Norwegian University of Science and Technology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this open trial is to investigate the feasibility, acceptability, and effect
      of metacognitive therapy in patients with prolonged post-concussive symptoms after mild
      traumatic brain injury.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 2016</start_date>
  <completion_date type="Anticipated">April 2023</completion_date>
  <primary_completion_date type="Anticipated">April 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>symptoms assessed by Rivermead Post Concussion Symptoms Questionnaire</measure>
    <time_frame>baseline, immediately after last therapy session, 10 weeks after completed therapy, 6 months after completed therapy</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Conners CPT-III</measure>
    <time_frame>2 pre-treatment baseline measures, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>D-KEFS Trail Making Test</measure>
    <time_frame>baseline, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Color-Word Interference Test</measure>
    <time_frame>baseline, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>D-KEFS Verbal Fluency</measure>
    <time_frame>baseline, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Symbol Digit Modality Test</measure>
    <time_frame>baseline, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Behavior Rating Inventory-Adult version (BRIEF-A)</measure>
    <time_frame>baseline, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The metacognitive beliefs questionnaire (MCQ-30)</measure>
    <time_frame>baseline, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatigue questionnaire (FQ)</measure>
    <time_frame>baseline, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Brief Pain Inventory (BPI)</measure>
    <time_frame>baseline, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inventory of Interpersonal Problems 64 (IIP-64)</measure>
    <time_frame>baseline, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatigue severity scale (FSS)</measure>
    <time_frame>baseline, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SF-12</measure>
    <time_frame>baseline, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Resilience scale for Adults (RSA)</measure>
    <time_frame>baseline, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Epworth sleepiness scale (ESS)</measure>
    <time_frame>baseline, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insomnia severity Index (ISI)</measure>
    <time_frame>baseline, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck Depression Inventory (BDI)</measure>
    <time_frame>3 pre-treatment baseline measures, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck Anxiety Inventory (BAI)</measure>
    <time_frame>3 pre-treatment baseline measures, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive Attention Syndrome (CAS-1)</measure>
    <time_frame>3 pre-treatment baseline measures, session to session (10 sessions), immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Brain Injuries</condition>
  <condition>Post-Concussive Symptom</condition>
  <condition>Post-Concussive Syndrome</condition>
  <arm_group>
    <arm_group_label>Metacognitive therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Metacognitive therapy, one 45-60 min session weekly during 10 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Metacognitive therapy</intervention_name>
    <arm_group_label>Metacognitive therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Patients with prolonged recovery after mild TBI (GCS &gt;12) will be recruited to our study if
        they have post concussive symptoms &gt; 6 months after injury.

        Patients will be recruited from an ongoing cohort study investigating mild and moderate TBI
        at St. Olavs Hospital and Trondheim Municipality Emergency Clinic, and in addition (as of
        October 2017) among TBI patients at St Olavs Hospital who were not included in the cohort
        study.

        Inclusion criteria

          -  Aged â‰¥between 16 and &lt; 60 years

          -  Have sustained a traumatic brain injury

        Exclusion criteria

          -  Severe TBI (GCS score 8 or less)

          -  Non fluency in Norwegian

          -  Living outside of Norway

          -  Major other trauma with high risk of disability lasting more than 3 months.

          -  Major incidental intracranial findings in acute MRI e.g. cyst, tumor, malformation,
             infarctions.

          -  Severe psychiatric, neurological or medical disease, including: Psychotic disorders,
             bipolar disorder, ongoing severe depressive episode

               -  Personality disorders affecting adherence to the research protocol

               -  Alcohol/drug abuse affecting adherence to the research protocol

               -  Mental retardation, autism or other severe developmental disorders

               -  Prior complicated mild, moderate or severe TBI

               -  Stroke or other acquired brain injuries

               -  Progressive neurological disorders (e.g. Parkinson's disease, MS)

               -  Advanced cancer, heart- or respiratory disease or other somatic diseases that
                  interfere with function.

               -  Major other trauma e.g. spinal cord injury

        In addition to exclusion criteria already employed in the cohort study, patients with
        co-occurring psychiatric disorders that necessitate referral to specific treatment
        according to existing guidelines will be excluded from the current intervention study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Magne Arve Flaten, phd</last_name>
    <role>Study Director</role>
    <affiliation>Norwegian University of Science and Technology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alexander Olsen</last_name>
    <email>alexander.olsen@ntnu.no</email>
  </overall_contact>
  <location>
    <facility>
      <name>Psykologisk Institutt, Dragvoll</name>
      <address>
        <city>Trondheim</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexander Olsen</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 17, 2016</study_first_submitted>
  <study_first_submitted_qc>February 19, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 24, 2016</study_first_posted>
  <last_update_submitted>October 20, 2017</last_update_submitted>
  <last_update_submitted_qc>October 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Psychotherapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Brain Injuries, Traumatic</mesh_term>
    <mesh_term>Brain Concussion</mesh_term>
    <mesh_term>Post-Concussion Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

